Your browser doesn't support javascript.
loading
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer.
Varkaris, Andreas; Katsiampoura, Anastasia; Davis, Jennifer S; Shah, Neeraj; Lam, Michael; Frias, Rosa Lizeth; Ivan, Cristina; Shimizu, Masayoshi; Morris, Jeffrey; Menter, David; Overman, Michael; Tran, Hai; Heymach, John; Chun, Yun Shin; Vauthey, Jean-Nicolas; Calin, George; Kopetz, Scott.
Affiliation
  • Varkaris A; Department of Hematology Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Katsiampoura A; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Davis JS; St. Elizabeth's Medical Center, Boston, MA, USA.
  • Shah N; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lam M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Frias RL; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ivan C; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Shimizu M; Department of Experimental Therapeutics, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Morris J; Department of Experimental Therapeutics, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Menter D; Department of Biostatistics, Division of Science, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Overman M; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tran H; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heymach J; Department of Thoracic/Head and Neck Medical Oncology - Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chun YS; Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vauthey JN; Hepato-Pancreato-Biliary Section, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Calin G; Hepato-Pancreato-Biliary Section, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kopetz S; Department of Experimental Therapeutics, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Cancer ; 120(3): 340-345, 2019 02.
Article in En | MEDLINE | ID: mdl-30636774
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Interleukin-8 / Interleukin-6 / MicroRNAs / Inflammation Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2019 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Interleukin-8 / Interleukin-6 / MicroRNAs / Inflammation Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2019 Document type: Article Affiliation country: Estados Unidos